Korenberg Matthew E
Lifecore Biomedical, Inc. · Director
Korenberg Matthew E is listed in filings as Director at Lifecore Biomedical, Inc.. This profile follows SEC Form 4 activity through Jun 5, 2026, including sale activity. Recent filings connect the profile to Lifecore Biomedical, Inc. (LFCR), Palvella Therapeutics, Inc. (PVLA), and Ligand Pharmaceuticals Incorporated - Common Stock (LGND). The current snapshot covers public activity from Jul 2, 2024 to Jun 5, 2026. Reported amounts are shown as $3.4M to $79.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $653k6.3k shares | SellSep 20, 2024 | $104.10 | $293.99 | |
| $649k6.2k shares | SellAug 26, 2024 | $105.02 | $293.99 | |
| $554k5.2k shares | SellAug 26, 2024 | $106.32 | $293.99 | |
| $449k4.3k shares | SellAug 23, 2024 | $105.13 | $293.99 | |
| $212k2k shares | SellAug 23, 2024 | $104.09 | $293.99 | |
| $122k1.2k shares | SellAug 22, 2024 | $105.54 | $293.99 | |
| $2M18.2k shares | SellAug 9, 2024 | $98.50 | $293.99 |